Avacta, ADC Theraputics sign collaboration and option agreement by Anna Smith | Oct 10, 2019 | News | 0 The partnership will focus on developing potent Affimer-drug conjugates. Read More
Avacta, Glythera link to develop drug conjugates by Selina McKee | Jan 16, 2018 | News | 0 UK companies Avacta and Glythera have sealed a licensing deal to develop drug conjugates using their combined technologies. Read More